. Toxicol. Sci. 45,[88][89][90][91][92][93] Oleanolic acid (OA) has been shown to inhibit mouse skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate (TPA). This study was designed to examine the effect of OA on the TPAinduced expression of the ornithine decarboxylase (ODC) gene as well as other genes. OA inhibited the induction of ODC activity and mRNA level produced by TPA in the skin of female CD-I mice. Preapplication of OA (10 junol) to the mouse dorsal skin produced an approximately 50% decrease in TPA (8 nmol>in-duced epidermal ODC activity, as well as ODC gene expression. These results suggest that OA inhibits TPA-induced ODC mainly at the transcriptional level. In addition to ODC, TPA also stimulated metallothionein (MT) gene expression in mouse skin. A dose of 2.5 funol of OA diminished the TPA-induced MT mRNA 50%. Treatment with OA (10 junol) after TPA (8 nmol) application also inhibited ODC and MT gene expression which suggests that OA does not compete with TPA for its receptor. OA pretreatment also prevented c-fos gene expression. All of these findings suggest that OA diminishes some signal transduction pathways of TPA to suppress target gene expression in mouse skin. This study suggests that OA might be a general inhibitor against TPA-stimulated gene expression in mouse skin, o ism Sodety of Tabcotogjr.
Oleanolic acid (3P-hydroxy-olea-12-en-28-oic acid; OA) is a triterpenoid compound that exists widely in natural plants (Wang and Jiang, 1992; Liu, 1995) . Both OA and ursolic acid, an isomer of OA, have been shown to have anti-tumor-promoting effects and to protect against acetaminophen-or Cdmediated hepatic injury in experimental animals (Tokuda et al, 1986; Liu et al., 1993 Liu et al., , 1995 Liu, 1995) . Both triterpenoids also possess antiinflammatory activity and a protective effect against lipid peroxidation Nagarajan, 1991, 1992; Najid et al, 1992) as do many other anti-tumor promoters (Verma, 1988; Conney et al., 1991; Huang et al, 1994) .
12-O-Tetradecanoylphorbol-13-acetate (TPA), a wellknown tumor promoter, induces ornithine decarboxylase (ODC), which is a rate-limiting enzyme in polyamine biosynthesis and a tumor promoter marker in mouse skin (Boutwell et al., 1983; Verma, 1988) . Topical application of TPA to mouse skin in vivo has been reported to cause transient induction of several genes, including metallothionein (MT), ODC, and early response genes, such as c-fos and c-jun (Rose-John et al, 1988; Bohm et al, 1990) . Mechanistic studies on the effects of TPA have shown that it binds to and activates protein kinase C, which starts the protein kinase cascade. This finally leads to formation of activated protein 1 (AP-1), which induces expression of target genes (Thomas et al, 1992; Tseng et al, 1994) .
OA has been shown to prevent TPA-mediated tumor promotion (Tokuda et al, 1986) and implanted tumor growth in mice (Hsu et al, 1997) . However, the biochemical basis of these interesting inhibitory effects of OA on tumor promotion remains to be determined. In the present study, we examined the effect of OA on ODC activity and gene expression produced by TPA in mouse skin. We studied the effect of OA on TPA-induced MT, c-fos, and c-jun gene expression.
sulfoximide and acetone (1:40) was applied. In some experiments, OA (10 funol/0.2 ml/mouse) was applied just after TPA application.
Sample preparation and enzyme assay. The epidermis was retrieved by the method of O'Brien et al. (1975) as described previously (Ishizaki el al., 1996) . Namely, the excised dorsal skins were plunged first into ice-cold water for 60 s, then into water at 55°C for 30 s, and reimmersed in ice-cold water. The epidermal layer was scraped off with a razor blade and homogenized in 50 raM sodium phosphate buffer, pH 7.2, containing 1 mM dithiothreitol, 0.1 mM pyridoxal phosphate, and 0.1 mM EDTA, using a sonicator (19 W, 2 min). The supernatant fraction obtained after centrifugation (30,000g for 20 min at 4°C) was used for determination of ODC activity. Epidermal ODC activity was determined by the method of Russell and Snyder (1968) as described previously (Ishizaki et al, 1996) . Briefly, the reaction mixture for the ODC assay comprised 0.2 M sodium phosphate buffer (pH 7.2), containing 0.8 mM pyridoxal phosphate, 2 mM dithiothreitol, and bovine serum albumin (BSA, 0.5 mg), 0.4 mM L-omithine hydrochloride with 0.4 fiCi/ml DL-[l-'
4 C]ornithine hydrochloride, and 0.2 ml of epidermal supernatant fraction in a final volume of 0.5 ml. After the reaction (37°C, 30 min) was stopped with 2 M citric acid, the radioactivity of I4 CO 2 , which absorbed to filter paper saturated with p-phenethylamine during the reaction, was measured using a liquid scintillation counter. Protein concentration in the epidermal extracts was measured by the method of Lowry et al. (1951) . ODC activity was expressed as pmolCO^O min/mg protein.
RNA preparation and Northern blot. The epidermal cells are mainly responsible for the activation of ODC by TPA in mouse skin (Kono et al., 1991) . As the amount of epidermis for RNA extraction from each mouse was limited, we used the skin (both epidermis and dermis) for RNA preparation. Total RNA was isolated from the skin of each mouse using the acid guanidine thiocyanate-phenol-chloroform extraction method (Chomczynski and Sacchi, 1987) as described previously . Total RNA (20 jig) was fractionated on a 1.2% agarose-formaldehyde gel and transferred onto a nylon membrane. The fixed RNA was hybridized with 32 P-labeled cDNA for ODC (0.72 kb, EcoRI fragment of pMK934 mODC cDNA, ATCC, Gaithersburg MD), c-fos [1.7 kb, EcoRUPstl fragment of pSPT-fos cDNA; JCRB, Tokyo, Japan (van Straaten et al., 1983) ], c-jun [2.1 kb, EcoRl/Clal fragment of pBS rcjun-2 cDNA, Riken, Tokyo, Japan (Kitabayashi et al., 1990) ], MT-1 (0.4 kb, HindlWEcoRl fragment of mouse pMT-1 cDNA), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH; 0.5 kb, Pst\ fragment of GAPDH cDNA). GAPDH was used as a control and was not affected by TPA or OA. The hybridization levels were semiquantitated with an autoradiographic scanner (bioimaging analyzer, BAS3000, Fuji Photo Film Co., Tokyo, Japan). Relative mRNA contents were normalized with GAPDH mRNA.
Statistical analysis. The data were subjected to statistical analysis by Kruskal-Wallis nonparametric ANOVA test followed by Dunn's multiple comparison test. The accepted level of significance was set at p < 0.05.
RESULTS
The effect of OA on TPA-induced ODC activity in mouse epidermis is illustrated in Fig. 1 . TPA (8 nmol) induced ODC activity in mouse epidermis dramatically; about an 18-fold increment in ODC activity was seen 4 h after TPA application. OA pretreatment (10 ftmol) significantly inhibited ODC induction after TPA application. The ODC activity at 4 h diminished to about an 8-fold increase with pretreatment with OA.
Because OA inhibited TPA-induced ODC activity in mouse epidermis, we next examined the effect of OA on TPA-mediated ODC gene expression. The representative result for Northern blot and the semiquantified result of blots are shown in Fig.  2A and 2B, respectively. TPA (8 nmol) markedly increased ODC mRNA, with the maximal expression (10-fold) occurring OA (10 jimol) was applied 30 min before TPA (8 nmol) application on the mouse dorsal skin. The skin was collected at the times indicated, an epidermal supernatant fraction was obtained, and ODC activity was assayed as described under Materials and Methods. Symbols represent the mean ± SE for three mice. *Significantly different from the control at p < .05. #Significantly different from TPA alone at p < .05. 4 h after TPA application. This is in agreement with a previous report (Lu et al, 1993) . OA alone did not affect the ODC mRNA level 4 h after the treatment (Fig. 2D) . OA (10 pimol) pretreatment markedly decreased the TPA-mediated induction of ODC mRNA, decreasing the maximum response approximately 70% at 4 h.
TPA is also known to increase MT gene expression in mouse skin. Because OA inhibited TPA-evoked induction of ODC mRNA, we also examined whether OA would inhibit TPAinduced MT mRNA expression. The representative result for Northern blot and the semiquantified result of blots are shown in Fig. 2A and 2C , respectively. TPA induced MT mRNA about 7-fold in accordance with the results reported by other investigators (Hashiba et al., 1989) . OA inhibited the MT gene expression induced by TPA treatment by approximately 85%. OA alone did not change the MT mRNA level (Fig. 2D) .
The effect of various doses of OA on TPA-induced increases in ODC and MT mRNAs was investigated (Fig. 3) . A dose of 2.5 pmol of OA inhibited ODC mRNA induction by TPA 50% at 4 h. With the higher dose of 10 /i,mol of OA, about a 60% decreases in the TPA-mediated increase in ODC was observed. Higher doses of OA were not used because of its low solubility in ethanol. OA (2.5 /xmol) inhibited TPA-increased MT mRNA expression by 50%. However, higher doses of OA produced a similar inhibitory effect on the increased MT gene expression produced by TPA. To ensure that OA did not inhibit the receptor binding of TPA, mice were treated first with TPA, followed by OA, and thus the gene expression of ODC and MT was examined. Posttreatment with OA also inhibited expression of both ODC and MT genes produced by TPA.
Because TPA induces many immediate early genes other than ODC and MT in mouse skin, the effects of OA on the increase in c-fos and c-jun mRNAs produced by TPA were investigated (Fig. 4) . TPA increased c-fos mRNA 30 min to 1 h after the treatment (data not shown) and this result corresponds with the previous report (Hashimoto et al, 1990) . Therefore, the 30-min time point was selected for this study. TPA produced about a 10-fold increase in c-fos mRNA 30 min after application. OA at either 5 or 10 /xmol/mouse inhibited TPAmediated c-fos mRNA induction by about 40% of the induced level. In CD-I mouse skin, c-jun gene is expressed constitutively, which is in agreement with previous work (Hashimoto et al, 1990) . Under the experimental conditions, TPA did not increase c-jun mRNA up to 4 h after the treatment, though previous work showed a slight increase in c-jun mRNA around 1 h (Hashimoto et al., 1990) .
DISCUSSION
The effects of OA, a triterpenoid, on TPA-stimulated transcription of target genes in the skin of female CD-I mice has been examined in this study. OA was shown to inhibit TPAmediated ODC induction, both the enzyme activity and the mRNA expression, in mouse skin. Such an inhibitory effect of OA on TPA-mediated induction of ODC is compatible with the previously reported finding that OA acts as an anti-tumor promoter (Tokuda et al, 1986; Huang et al., 1994; Hsu et al, 1997) . In addition, this study has revealed that OA suppresses TPA-induced c-fos gene expression in mouse skin. TPA is thought to promote skin cancer through the overexpression of protooncogenes: c-fos, c-jun, and c-myc Kennard and Butler, 1991) . Therefore, the ability of OA to inhibit protooncogene c-fos expression by TPA could be related to its anti-tumor-promoting effect.
Expression of TPA-induced ODC activity is regulated at multiple steps, including the transcriptional rate of the ODC gene and the translational efficiency of ODC mRNA Blackshear, 1990, 1992; Tseng et al., 1994) . In this study, we found that OA had very similar inhibitory effects on the TPA-induced increases in ODC activity and mRNA level. Although we did not measure ODC activity after treatment with OA alone, OA did not increase in the ODC mRNA level at 4 h. These results suggest that the inhibitory effect of OA on the induction of ODC evoked by TPA is mediated at the transcriptional level of ODC.
It has been reported that the hepatoprotective effect of OA on Cd-induced hepatotoxity is due to the increased MT gene expression (Liu etal., 1993 (Liu etal., , 1995 . However, the present study illustrates that OA does not induce, but rather inhibits MT gene expression produced by TPA in mouse skin. These results indicate that OA acts differently in various organs. At this time, we do not know the reason for this phenomenon, and further research is required.
TPA interacts with the receptor, protein kinase-C, and via the mitogen-activated protein kinase pathway, AP-1 is activated to express transcription of target genes (Boutwell et al., 1983; Tseng et al., 1994) . Because in the present study OA modified the expression of c-fos, ODC, and MT genes, OA could affect this signal transduction pathway or interact with the receptor for TPA. However, the observation that the application of OA after TPA treatment also had an inhibitory effect on expression of both ODC and MT genes, suggests that OA is not likely to interact with protein kinase C. Therefore, it is possible that OA inhibits somewhere else in the signal transduction pathway of TPA.
CONCLUSION
This study has revealed that OA inhibits expression of ODC, MT, and c-fos genes evoked by TPA in the mouse skin. Therefore, OA might be a general suppressor for TPA-induced gene expression. The inhibition of c-fos and ODC expression provides an explanation for the effects of OA as an anti-tumor promoter to TPA. This result suggestes that OA has influences the action of other promoters.
